Healthcare · Drug Manufacturers - Specialty & Generic
Neuland Laboratories Ltd.
NEULANDLAB
Financials as of(≥90-day lag, SEBI compliant)
Neuland Laboratories Limited engages in the manufacture and sale of active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. It also provides custom manufacturing solutions, as well as peptide synthesis services. Neuland Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.
NSE: NEULANDLABOfficial website ↗
Key metrics
Market Cap
₹19,201 cr
P/E Ratio
107.53x
P/B Ratio
12.59x
ROE
17.06%
ROCE
20.94%
Debt / Equity
0.1x
Net Margin
18.13%
Dividend Yield
8%
EPS
₹202.74
Period
FY2025
Shareholding pattern
As of LatestPromoter: 37.96%FII: 26.97%Public: 35.07%
Deep-dive pages
Educational content — not investment adviceThis page presents publicly available information about Neuland Laboratories Ltd. for educational purposes only. EquitiesIndia.com is not a SEBI-registered Investment Adviser or Research Analyst. Nothing here constitutes investment advice, a recommendation to buy or sell any security, or a solicitation to transact. All financial data shown is sourced from public BSE/NSE filings and is at least 90 days old. Past performance is not indicative of future results. Please consult a SEBI-registered adviser before making any investment decision.